Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19

dc.creatorGOMES, FERNANDA C.G.
dc.creatorNAURATH, CHRISTIAN
dc.creatorAZEVEDO, LUCIANE H.
dc.creatorZEZELL, DENISE M.
dc.date2021
dc.date2022-03-14T11:46:08Z
dc.date2022-03-14T11:46:08Z
dc.date.accessioned2023-09-28T14:21:20Z
dc.date.available2023-09-28T14:21:20Z
dc.identifier2178-6011
dc.identifierhttp://repositorio.ipen.br/handle/123456789/32783
dc.identifier4
dc.identifier24
dc.identifierSuppl 1
dc.identifier10.4322/bds.2021.e2962
dc.identifier0000-0001-7404-9606
dc.identifierSem Percentil
dc.identifier33.00
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9003002
dc.descriptionObjective: The purpose of this short communication is to show that although photobiomodulation in the treatment of neurophathic oral pain after COVID-19 contagion could be an option, photobiomodulation is not a new technique. PBMT was used with different protocols and pain was assessed using VAS (visual analogue scale - 0 until 10) before and after the consultation. Results: Evolution of VAS during the sessions showed a decrease in painful symptomatology as treatment was performed. Conclusion: Based on the results obtained in the present case report, we concluded that PBMT with the parameters used in this clinical case was an effective, noninvasive and a new option of treatment for neuralgia resulting from COVID-19.
dc.format1-5
dc.relationBrazilian Dental Science
dc.rightsopenAccess
dc.subjectlight emitting diodes
dc.subjecttherapy
dc.subjectcoronaviruses
dc.subjectnerves
dc.subjectpain
dc.titlePhotobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19
dc.typeArtigo de peri??dico
dc.coverageI


Este ítem pertenece a la siguiente institución